Mabtas (Rituximab injection)

Mabtas (Rituximab injection)

Brand: Intas
Product Code: PSAM3031445
Availability: In Stock
Price: $1,498.00
    - OR -   Add to Wish List
Add to Compare

Mabtas (Rituximab injection)

Mabtas (Rituximab injection) contains an antibody Mabtas (Rituximab injection) which is a type of protein. Rituximab is in a class of medications called biologic antineoplastic agents. This drug is a type of monoclonal antibody, designed to target specific proteins on B-cells. Rituximab binds to the surface of a type of white blood cell, the B lymphocyte. When Mabtas (Rituximab injection) binds to the surface of this cell it causes the cell to die.


Mabtas (Rituximab injection) is indicated for the treatment of

  •     Non-Hodgkin’s Lymphoma
  1.         Patients with relapsed or chemo resistant indolent B cell Non-Hodgkin’s Lymphoma
  2.         Previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy
  3.         For patient with relapsed/ refractory follicular lymphoma as maintenance therapy after responding to induction therapy with chemotherapy
  4.         Patients with CD20 positive diffuse large B cell Non- Hodgkin's lymphoma in combination with CHOP (Cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy
  •     Chronic Lymphocytic Leukemia
  1.         Mabtas (Rituximab injection) in combination with chemotherapy is indicated for the treatment of patient with previously untreated and relapsed/refractory Chronic Lymphocytic Leukemia
  •     Rheumatoid Arthritis
  1.         Adult patients with active rheumatoid arthritis who have had an inadequate response or intolerance to one or more Tumour Necrosis Factor inhibitor therapies

Write a review

Your Name:

Your Review: Note: HTML is not translated!

Rating: Bad           Good

Enter the code in the box below:

Powered By pshealth
Pharmacyanddrug © 2018.